HILLESTAD PHARMACEUTICALS INC.
|
|||
| Mailing Address: | AVE 178 U.S. HWY. 51 N. WOODRUFF, WI 54568 |
Head Office Address: | AVE 178 U.S. HWY. 51 N. WOODRUFF, WI 54568 |
| Contact Name: | Dan Hillestad | Principal Regulator: | British Columbia |
| Business e-mail address: | corporate@hillestadlabs.com | Short Form Prospectus Issuer: | No |
| Telephone Number: | 800 535-7742 | Reporting Jurisdictions: | British Columbia, Alberta |
| Fax Number: | 715 358-7812 | Stock Exchange: | N/A |
| Date of Formation: | May 26 1983 | Stock Symbol: | |
| Jurisdiction Where Formed: | B.C. | Auditor: | Buckley Dodds CPA |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | NA |
| CUSIP Number: | 43157H | Transfer Agent: | Computershare Trust Company of Canada |
| Financial Year-End: | Sep 30 | Size of Issuer (Assets): | Under $5,000,000 |
|
